1.50
price down icon9.64%   -0.16
pre-market  Vorhandelsmarkt:  1.45   -0.05   -3.33%
loading

Medicinova Inc Aktie (MNOV) Neueste Nachrichten

pulisher
03:36 AM

MediciNova (NASDAQ:MNOV) Share Price Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat

03:36 AM
pulisher
01:29 AM

Key resistance and support levels for MediciNova Inc.July 2025 Analyst Calls & Growth Focused Investment Plans - newser.com

01:29 AM
pulisher
Nov 03, 2025

Trend analysis for MediciNova Inc. this weekMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What’s next for MediciNova Inc. stock priceOptions Play & Daily Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Applying big data sentiment scoring on MediciNova Inc.July 2025 Setups & Free Accurate Trade Setup Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is MediciNova Inc. stock a contrarian buyEarnings Overview Summary & Fast Exit and Entry Trade Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will MediciNova Inc. stock maintain growth storyWeekly Stock Summary & Daily Stock Trend Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What Fibonacci levels say about MediciNova Inc. rebound2025 Earnings Impact & Weekly Market Pulse Updates - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Market reaction to MediciNova Inc.’s recent newsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What dividend safety score for MediciNova Inc. stockStop Loss & Momentum Based Trading Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

3 Penny Stocks With Market Caps Over $80M To Consider - simplywall.st

Nov 03, 2025
pulisher
Nov 03, 2025

How currency fluctuations impact MediciNova Inc. stockWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Applying Elliott Wave Theory to MediciNova Inc.Trend Reversal & Weekly Setup with High ROI Potential - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will MediciNova Inc. stock remain a Wall Street favorite2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Developing predictive dashboards with MediciNova Inc. dataWeekly Trade Review & Weekly Top Gainers Trade List - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

MediciNova Research Sparks New Hope for Atherosclerosis Therapy - StocksToTrade

Nov 02, 2025
pulisher
Nov 02, 2025

MediciNova’s Breakthrough Strategy in Atherosclerosis Treatment - timothysykes.com

Nov 02, 2025
pulisher
Nov 01, 2025

MediciNova, Inc. (MNOV) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 01, 2025
pulisher
Nov 01, 2025

MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’ - Stocktwits

Nov 01, 2025
pulisher
Nov 01, 2025

Will MediciNova Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Verified Technical Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

MediciNova Advances Atherosclerosis Research with Novel Therapeutic Strategy​ - StocksToTrade

Nov 01, 2025
pulisher
Nov 01, 2025

MediciNova’s New Research Drives Strategic Focus on Cholesterol Metabolism - timothysykes.com

Nov 01, 2025
pulisher
Oct 31, 2025

MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

MediciNova Stock Surge: Unveiling the Latest Development - timothysykes.com

Oct 31, 2025
pulisher
Oct 31, 2025

MediciNova (MNOV) Analyst Ratings: Consistent 'Buy' Rating Maint - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - Nasdaq

Oct 31, 2025
pulisher
Oct 30, 2025

Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading? - Benzinga

Oct 30, 2025
pulisher
Oct 30, 2025

MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in ... - Enidnews.com

Oct 30, 2025
pulisher
Oct 30, 2025

MediciNova, Inc. Publishes Research on MN-002's Potential in Atherosclerosis Treatment in Journal of Atherosclerosis and Thrombosis - Quiver Quantitative

Oct 30, 2025
pulisher
Oct 30, 2025

MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

MediciNova (NASDAQ: MNOV) publishes tipelukast data: MN-002 enhances cholesterol efflux - Stock Titan

Oct 30, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):